title: Structural abnormalities of the cornea and lid resulting from collagen V mutations.
abstract: OBJECTIVE
  Type V collagen forms heterotypic fibrils with type I collagen and accounts for 10% to 20% of corneal collagen. The purpose of this study was to define the ocular phenotype resulting from mutations in the type V collagen genes COL5A1 and COL5A2 and to study the pathogenesis of anomalies in a Col5a1-deficient mouse.
  
  
  METHODS
  Seven patients with classic Ehlers-Danlos syndrome (EDS) due to COL5A1 haploinsufficiency and one with an exon-skipping mutation in COL5A2 underwent an ocular examination, corneal topography, pachymetry, and specular microscopy. A Col5a1-haploinsufficient mouse model of classic EDS was used for biochemical and immunochemical analyses of corneas. Light and electron microscopy were used to quantify stromal thickness, fibril density, fibril structure, and diameter.
  
  
  RESULTS
  Five males and three females (mean age, 26 +/- 13.57 years; range, 11-52) were studied. All patients had "floppy eyelids." The corneas of all eyes were thinner (mean corneal thickness: 435.75 +/- 12.51 microm) when compared with control corneas (568.89 +/- 28.46 microm; P < 0.0001). In the Col5a1+/- mouse cornea, type V collagen content was reduced by approximately 49%, and stromal thickness was reduced by approximately 26%. Total collagen deposition in Col5a1(+/-) corneas also was reduced. Collagen fibril diameters were increased, but fibril density was decreased throughout the stroma at all developmental stages.
  
  
  CONCLUSIONS
  In the eye, COL5A1 and COL5A2 mutations manifest as abnormally thin and steep corneas with floppy eyelids. Mechanisms involved in producing the latter anomalies probably involve altered regulation of collagen fibrillogenesis due to abnormalities in heterotypic type I/V collagen interactions similar to those observed in the Col5a1+/- mouse cornea.
authors.affiliation: Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Fani
authors.initials: F
authors.lastname: Segev
authors.forename: Elise
authors.initials: E
authors.lastname: Héon
authors.forename: William G
authors.initials: WG
authors.lastname: Cole
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Wenstrup
authors.forename: Felix
authors.initials: F
authors.lastname: Young
authors.forename: Allan R
authors.initials: AR
authors.lastname: Slomovic
authors.forename: David S
authors.initials: DS
authors.lastname: Rootman
authors.forename: Diana
authors.initials: D
authors.lastname: Whitaker-Menezes
authors.forename: Inna
authors.initials: I
authors.lastname: Chervoneva
authors.forename: David E
authors.initials: DE
authors.lastname: Birk
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D015153:Blotting, Western; D002648:Child; D024062:Collagen Type V / Q000235:genetics* / Q000378:metabolism; D003317:Corneal Dystrophies, Hereditary / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D019781:Corneal Topography; D004195:Disease Models, Animal; D004535:Ehlers-Danlos Syndrome / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005141:Eyelid Diseases / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D008297:Male; D051379:Mice; D046529:Microscopy, Electron, Transmission; D008875:Middle Aged; D009154:Mutation; D010375:Pedigree; D010641:Phenotype
chemical_list: D024062:Collagen Type V